Typical Danish Caucasian type 2 diabetic patients do not commonly carry genetic variants in GIP and GLP-1 encoding regions of the proGIP and proglucagon genes

Regulatory Peptides

Volumn 119, Issue 3, 2004, Pages 151-154

  Ørskov, Cathrine ^a   Hjorth, Siv A ^b   Jensen, Anne D ^c   Vilsbøll, Tina ^d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NOVO NORDISK A S   (Denmark)

^c Maxygen APS   (Denmark)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Gastric inhibitory polypeptide (GIP); Germ line mutation; Glucagon like peptide 1 (GLP 1); Incretin; Type 2 diabetes

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GENOMIC DNA; GLUCAGON LIKE PEPTIDE 1; PROGLUCAGON;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; GENETIC VARIABILITY; GERM LINE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEX RATIO;

AGED; BASE SEQUENCE; DENMARK; DIABETES MELLITUS, TYPE 2; DNA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; GENETIC PREDISPOSITION TO DISEASE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PHENOTYPE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; RECEPTORS, GASTROINTESTINAL HORMONE; RECEPTORS, GLUCAGON; SEQUENCE ANALYSIS, DNA;

EID: 2142821389     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2004.03.007     Document Type: Article

References (23)

1. Ebert R., Creutzfeldt W. Gastric inhibitory polypeptide. Clin. Gastroenterol. 9:1980;679-698
2. Kreymann B., Williams G., Ghatei M.A., Bloom S.R. Glucagon like peptide-1 7-36: a physiological incretin in man. Lancet. 8571:1987;1300-1304
3. Ørskov C. Glucagon-like peptide-1, a new hormone of the entero-insular axis. Diabetologia. 35:1992;701-711
4. Scrocchi L.A., Brown T.J., MaClusky N., Brubaker P.L., Auerbach A.B., Joyner A.L., et al. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat. Med. 11:1996;1254-1258
5. Miyawaki K., Yamada Y., Yano H., Niwa H., Ban N., Ihara Y., et al. Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc. Natl. Acad. Sci. U. S. A. 96:1999;14843-14847
6. Tseng C.C., Boylan M.O., Jarboe L.A., Usdin T.B., Wolfe M.M. Chronic desensitisation of the glucose-dependent insulinotropic polypeptide receptor in diabetic rats. Am. J. Physiol. 270:1996;E661-E666
7. Miyawaki K., Yamada Y., Ban N., Ihara Y., Tsukiyama K., Zhou H., et al. Inhibition of gastric inhibitory polypeptide signalling prevents obesity. Nat. Med. 7:2002;738-742
8. Nauck M., Stöckmann F., Ebert R., Creutzfeldt W. Reduced incretin effect in type 2 (non-insulin dependent) diabetes. Diabetologia. 29:1986;46-52
9. Nauck M.A., Heimesaat M.M., Ørskov C., Holst J.J., Ebert R., Creutzfeldt W. Perserved incretin activity of glucagon-like peptide-1 (7-36 amide) but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J. Clin. Invest. 91:1993;301-307
10. Vilsbøll T., Krarup T., Deacon C.F., Madsbad S., Holst J.J. Reduced postprandial concentrations of intact biologically active glucagons-like peptide-1 in type 2 diabetic patients. Diabetes. 50:2001;609-613
11. Nauck M.A., Kleine N., Ørskov C., Holst J.J., Wilms B., Creutzfeldt W. Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 8:1993;741-744
12. Holst J.J. Gastric inhibitory polypeptide analogous: do they have a therapeutic role in diabetes mellitus similar to that of glucagon-like peptide-1? BioDrugs. 3:2002;175-181
13. Holst J.J., Gromada J., Nauck M.A. The pathogenesis of NIDDM involves a defective expression of the GIP receptor. Diabetologia. 8:1997;984-986
14. Meier J.J., Nauck M.A., Schmidt W.E., Gallwitz B. Gastric inhibitory polypeptide: the neglected incretin revisited. Regul. Pept. 107:2002;1-13
15. Kubota A., Yamada Y., Hayami T., Yyasuda K., Someya Y., Ihara Y., et al. Identification of two missense mutations in the GIP receptor gene: a functional study and association analysis with NIDDM: no evidence of association with Japanese NIDDM subjects. Diabetes. 45:1996;1701-1705
16. Almind K., Ambye L., Urhammer S.A., Hansen T., Echwald S.M., Holst J.J., et al. Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chines hamster fibroblast cells. Diabetologia. 41:1998;1194-1198
17. Nauck M., Hahn S., Sauerwald A., Schmiegel W. Lack of germline mutations in the preproglucagon gene region coding for glucagon-like peptide-1 in type 2 diabetic (NIDDM) patients. Exp. Clin. Endocrinol. Diabetes. 108:2000;72-75
18. Bell G.I., Sanchez-Pescador R., Laybourn P.J., Najarian R.C. Exon duplication and divergence in the human preproglucagon gene. Nature. 304:1983;368-371
19. Inagaki N., Seino Y., Takeda J., Yano H., Yamada Y., Bell G.I., et al. Gastric inhibitory polypeptide: structure and chromosomal localization of the human gene. Mol. Endocrinol. 3:1989;1014-1021
20. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turcer R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma-glucose and insulin concentrations in man. Diabetologia. 28:1985;412-419
21. Mortensen K., Christensen L.L., Holst J.J., Ørskov C. GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine. Regul. Pept. 114:2003;189-196
22. Vilsbøll T., Krarup T., Sonne J., Madsbad S., Vølund A., Juul A.G., et al. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 88:2003;2706-2713
23. Wisen O., Johansson C. Gastrointestinal function in obesity: motility, secretion, and absorption following a liquid test meal. Metabolism. 41:1992;390-395